ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > Cell > Organoids > CIPC-CWC002

Human iPSC-Derived Ventricular Cardiomyocytes

This product is still under development. Please contact us if you have interest in this product. We will accelerate the development process accordingly and reserve this product for you as request.
  • Product Details
    Human iPSC-Derived Ventricular Cardiomyocytes are specialized cells that closely mimic the properties of human ventricular heart cells, essential for cardiovascular research and drug development. Our Human iPSC-derived ventricular cardiomyocytes are differentiated from human induced pluripotent stem cells (iPSCs) using a fully defined, proprietary cardiac differentiation protocol.

    These cardiomyocytes are thoroughly characterized through immunocytochemistry, targeting well-known markers such as MYL2 and cTNT, ensuring their ventricular-specific identity and functionality. They have been validated for their ability to exhibit ventricular-like electrophysiological properties and responsiveness to cardiotoxic drugs.

    Additionally, our ventricular cardiomyocytes are cryopreserved at an optimal stage of differentiation, ensuring their functionality and readiness for immediate use upon thawing. This guarantees a consistent and reliable cell source for research into ventricular fibrillation, ventricular-specific cardiac conditions, and cardiac toxicity testing.
  • Product Specification
    Cryopreserved cells, shipped on dry ice. Each vial contains over 1 x 10^6 cells.
  • Storage

    Frozen in liquid nitrogen.

  • Clinical and Translational Updates

コメント (0)

価格(JPY) : Inquire

プロモーション&展示



データシート&ドキュメンテーション

関連製品一覧

新製品

お問い合わせ&コメント

This web search service is supported by Google Inc.

totopphone